Mark Schoenberg
Chief Medical Officer · UroGen Pharma Ltd.
- 2025
- Sep 9, 2026
- 12
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark Schoenberg files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jason Drew Smith - $212K in URGN purchases and sales in the last 12 months
- Chris Degnan - $81K in URGN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark Schoenberg?
Mark Schoenberg is a corporate insider, tracked as Chief Medical Officer of UroGen Pharma Ltd. (URGN). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mark Schoenberg submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Mark Schoenberg been buying or selling stock?
Recorded transactions: 0 open-market purchases and 13 open-market sales ($4.77M) across all tracked filings.
